3 New Strong Buy Ratings from Top-Rated Analysts: 12/26/2025
Here’s the good stuff from our most popular screener, curated and delivered:
- Discover why Orla Mining (ORLA) is our Stock of the Week
- Viatris (VTRS) is a low-priced stock with excellent potential
- Why Ross Stores (ROST) could benefit from the busy shopping season
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The AI That Could Triple Your Money This Year
Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with. For now, you can try this AI yourself, completely free of charge - no email, no credit card.
1. Orla Mining Ltd (NYSEMKT: ORLA)
Orla Mining is on a tear—trading near 52-week highs with explosive momentum, a stunning 203% return since 2020, and a top-tier #2 ranking in the gold industry.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $14.75 — get current quote
Max 1-year forecast: $27.00
Why we're watching:
- Only one analyst we track currently issues a rating on ORLA, but CiBC researcher Cosmos Chiu (a top 17% rated analyst) maintains a Buy rating with a $27.00 price target, representing +90.41% upside potential.
- The analyst remains bullish on the company's strategic initiatives to enhance operational efficiencies, with recent improvements and cost controls expected to significantly boost margins.
- ORLA was also a recent Stock of the Week pick — see why our Editor-in-Chief calls it “the best gold stock of 2026”
- Industry ranking context: ORLA is currently the 2nd highest-rated stock in the Gold industry, which has an Industry Rating of A.
- Zen Rating highlights: With its A (Strong Buy) rating, ORLA is in the top tier of the 4600+ stocks we track.
- Component Grades: Growth rated B (95th percentile) reflects forecasted EPS growth of 382.88% in the first year and 770.38% over two years, while Momentum rated A (85th percentile) captures the stock's 166.04% climb from its 52-week low. See all 7 Zen Component Grades here
2. Viatris Inc (NASDAQ: VTRS)
Viatris just unlocked fresh upside with FDA approval of generic Sandostatin and a strategic monetization of its Biocon Biologics stake, sharpening its capital allocation story.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $11.96 — get current quote
Max 1-year forecast: $15.00
Why we're watching:
- Analyst support: Both of the analysts we track covering VTRS rate it Strong Buy, reflecting strong conviction in the company's turnaround potential. See the ratings
- For example, Truist Securities researcher Srikripa Devarakonda (a top 13% rated analyst) initiated coverage on the stock with a Strong Buy rating and $15.00 price target, representing nearly 25% upside potential.
- The company's strategic decision to monetize its Biocon Biologics equity stake demonstrates management's focus on optimizing the capital structure and returning value to shareholders.
- Industry ranking context: VTRS is currently the 12th highest-rated stock out of 58 (See the rest of the stocks here) in the Pharmaceutical industry, which has an Industry Rating of B.
- Zen Rating highlights: VTRS is an A, or Strong Buy, rated stock. It ranks among the top-rated pharmaceutical companies with consensus analyst upside of nearly 25%.
- Component Grades: The stock earns solid B grades in both Value and Growth, indicating attractive valuation alongside expansion potential, complemented by a B rating in Safety. See all 7 Zen Component Grades here
3. Ross Stores (NASDAQ: ROST)
Ross Stores is a retail powerhouse—trading near 52-week highs with a $59B market cap and an eye-popping 7,900%+ return since 1997, ranking among the very best in apparel.
Zen Rating: B (Buy) — see full analysis
Recent Price: $182.41 — get current quote
Max 1-year forecast: $200.00
Why we're watching:
- Analyst support: The retail giant has strong Wall Street backing, with 8 Strong Buy and 2 Buy ratings RN, reflecting confidence in the discount retail model. See the ratings
- Wells Fargo's Ike Boruchow (a top 5% rated analyst) maintains a Strong Buy with a $200.00 price target (+9.64% upside), suggesting potential growth and solid market positioning with optimism around strategic initiatives led by management.
- Recent analyst commentary emphasizes market resilience, growth in same-store sales, and effective inventory management as key drivers, with expected new store openings and holiday sales providing catalysts.
- Industry ranking context: ROST is currently the 4th highest-rated stock in the Apparel industry, which has an Industry Rating of B.
- Zen Rating highlights: As a B (Buy) rated stock, ROST is in a class of stocks that have historically averaged 19.88% returns annually — better than the S&P.
- Component Grades: ROST has above-average Bs for Financials, Sentiment, and from our all-seeing AI Factor. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.